Gary Lopaschuk
Affiliations: | University of Alberta, Edmonton, Alberta, Canada |
Area:
Biochemistry, Molecular Biology, Recreation, Public HealthGoogle:
"Gary Lopaschuk"Mean distance: (not calculated yet)
Cross-listing: PHTree
Children
Sign in to add trainee| Que Liu | grad student | 2000 | University of Alberta |
| Arzu Onay-Besikci | grad student | 2003 | University of Alberta |
Collaborators
Sign in to add collaborator| Dunja Aksentijevic | collaborator | 2008-2023 | University of Alberta (Physiology Academic Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Darwesh AM, Fang L, Altamimi TR, et al. (2024) Cardioprotective effect of 19,20-epoxydocosapentaenoic acid (19,20-EDP) in ischemic injury involves direct activation of mitochondrial sirtuin 3. Cardiovascular Research |
| Alhasan KA, King MA, Pattar BSB, et al. (2024) Anaplerotic filling in heart failure: a review of mechanism and potential therapeutics. Cardiovascular Research |
| Fernandez-Patron C, Lopaschuk GD, Hardy E. (2024) A self-reinforcing cycle hypothesis in heart failure pathogenesis. Nature Cardiovascular Research. 3: 627-636 |
| Ketema EB, Lopaschuk GD. (2024) The role of acetylation in obesity-induced cardiac metabolic alterations. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques. 27: 13080 |
| Ho KL, Karwi Q, Wang F, et al. (2024) The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischemic heart failure. Cardiovascular Research |
| Pherwani S, Connolly D, Sun Q, et al. (2024) Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation. Metabolism: Clinical and Experimental. 154: 155818 |
| Ketema EB, Ahsan M, Zhang L, et al. (2024) Protein lysine acetylation does not contribute to the high rates of fatty acid oxidation seen in the post-ischemic heart. Scientific Reports. 14: 1193 |
| Sun Q, Güven B, Wagg CS, et al. (2024) Mitochondrial fatty acid oxidation is the major source of cardiac ATP production in heart failure with preserved ejection fraction. Cardiovascular Research |
| Cho S, Dadson K, Sung HK, et al. (2024) Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF). Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 171: 116119 |
| Güven B, Sun Q, Wagg CS, et al. (2024) Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction. The Journal of Pharmacology and Experimental Therapeutics. 388: 145-155 |